M L Hansmann
Overview
Explore the profile of M L Hansmann including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
208
Citations
2613
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Oberbeck S, Schrader A, Warner K, Jungherz D, Crispatzu G, von Jan J, et al.
Blood
. 2020 Dec;
136(24):2786-2802.
PMID: 33301031
T-cell prolymphocytic leukemia (T-PLL) is a poor-prognostic neoplasm. Differentiation stage and immune-effector functions of the underlying tumor cell are insufficiently characterized. Constitutive activation of the T-cell leukemia 1A (TCL1A) oncogene...
2.
[Revised version of the 4th edition of the WHO classification of malignant lymphomas : What is new?]
Ott G, Klapper W, Feller A, Hansmann M, Moller P, STEIN H, et al.
Pathologe
. 2018 Jul;
40(2):157-168.
PMID: 30019203
After 8 years, the WHO has now published the updated version of the 4th edition of the classification of hematopoietic and lymphoid tumors. This update provides a conceptual rewrite of...
3.
Klapper W, Fend F, Feller A, Hansmann M, Moller P, STEIN H, et al.
Pathologe
. 2018 Apr;
40(2):152-156.
PMID: 29666909
The update of the 4th edition of the WHO classification for hematopoietic neoplasms introduces changes in the field of mature aggressive B‑cell lymphomas that are relevant to diagnostic pathologists. In...
4.
Hirsch B, Endris V, Lassmann S, Weichert W, Pfarr N, Schirmacher P, et al.
Virchows Arch
. 2018 Jan;
472(4):557-565.
PMID: 29374318
The simultaneous detection of multiple somatic mutations in the context of molecular diagnostics of cancer is frequently performed by means of amplicon-based targeted next-generation sequencing (NGS). However, only few studies...
5.
Koch K, Hoster E, Ziepert M, Unterhalt M, Ott G, Rosenwald A, et al.
Ann Oncol
. 2016 Apr;
27(7):1323-9.
PMID: 27117536
Background: Histologically, follicular lymphoma (FL) grades 1, 2 and 3A are composed of two distinct cell types, centroblasts and centrocytes. FL grade 3B is composed only of centroblasts and has...
6.
Leich E, Hoster E, Wartenberg M, Unterhalt M, Siebert R, Koch K, et al.
Leukemia
. 2015 Dec;
30(4):854-60.
PMID: 26621338
Approximately 15% of follicular lymphomas (FLs) lack breaks in the BCL2 locus. The aim of this study was to better define molecular and clinical features of BCL2-breakpoint/t(14;18)-negative FLs. We studied...
7.
Teubner D, Kiesslich R, Hansmann M
Dtsch Med Wochenschr
. 2014 Aug;
139(36):1767-8.
PMID: 25157864
No abstract available.
8.
Hartmann S, Hansmann M
Pathologe
. 2013 Jan;
34(1):34-44.
PMID: 23319007
Immune suppression is a risk factor for malignant lymphoma development. Progress in medical science has increased the numbers of immunosuppressed patients due to organ transplantations or successful treatment of autoimmune...
9.
Barth T, Flossbach L, Bernd H, Bob R, Buck M, Cogliatti S, et al.
Pathologe
. 2012 Nov;
34(4):329-34.
PMID: 23179209
Background: The detection of characteristic genomic aberrations by fluorescence in situ hybridization (FISH) has a high diagnostic impact on lymphomas according to the World Health Organization (WHO). To investigate the...
10.
Esser R, Glienke W, Bochennek K, Erben S, Quaiser A, Pieper C, et al.
Klin Padiatr
. 2011 Nov;
223(6):326-31.
PMID: 22095188
Purpose: Real-time reverse-transcriptase PCR (RT-qPCR) or conventional RT-PCR (RT-cPCR) detection of tyrosine hydroxylase (TH) is increasingly used to detect neuroblastoma (NB) cells in clinical samples. However, TH expression in normal...